A Well-Being Intervention for People With IBS
ConditionIrritable Bowel Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Wisconsin, Madison
About this trial
The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and depression; increases self-esteem, empathy, and hope; and improves quality of life indicators such as IBS symptom severity, sleep quality, fatigue, and diet. Participants can expect to be on study for up to 9 months.
Eligibility criteria
Qualifiers
Men and women currently diagnosed with Irritable Bowel Syndrome (IBS) by a healthcare provider.
Able to read and write in English.
Willing to complete questionnaires and participate in either the intervention or control group.
Capable of providing informed consent.
Disqualifiers
Individuals with cognitive impairments or reading difficulties that would interfere with understanding study materials or completing assessments.
Individuals unable to provide informed consent.
Prior participation in a similar intervention study.
Non-English speakers (since study materials are in English)
Trial design
Treatments tested in this trial
- Well-Being Intervention
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov